A roadmap to evaluate the proteome-wide selectivity of covalent kinase inhibitors

作者：Bryan R. Lanning, Landon R. Whitby, M. Dix, J. Douhan, A. Gilbert, Erik C. Hett, T. O. Johnson, C. Joslyn, J. Kath, Sherry L. Niessen, Lee R. Roberts, M. Schnute, Chu Wang, Jonathan J. Hulce, B. Wei, L. Whiteley, M. Hayward, B. Cravatt · 发表于：Nature Chemical Biology · 年份：2014 · DOI：10.1038/nchembio.1582 · 被引用次数：333 · 研究领域：Biology、Medicine

Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active-sites have emerged as valuable probes and approved drugs. Many protein classes, however, possess functional cysteines and therefore understanding the proteome-wide selectivity of covalent kinase inhibitors is imperative. Here, we accomplish this objective using activity-based protein profiling coupled with quantitative mass spectrometry to globally map the targets, both specific and non-specific, of covalent kinase inhibitors in human cells. Many of the specific off-targets represent non-kinase proteins that, interestingly, possess conserved, active-site cysteines. We define windows of selectivity for covalent kinase inhibitors and show that, when these windows are exceeded, rampant proteome-wide reactivity and kinase target-independent cell death conjointly occur. Our findings, taken together, provide an experimental roadmap to illuminate opportunities and surmount challenges for the development of covalent kinase inhibitors.